12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pulmatrix, Cystic Fibrosis Foundation deal

Pulmatrix and the not-for-profit's Cystic Fibrosis Foundation Therapeutics Inc. drug discovery and development affiliate partnered to develop PUR118 to treat cystic fibrosis. Pulmatrix will receive up to $1.4 million in...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >